Subsidiary10 Jul 2026, 01:03 pm
Aurobindo Pharma Incorporates New Stepdown Subsidiary in Indonesia
AI Summary
Aurobindo Pharma Ltd has announced the incorporation of a new wholly owned stepdown subsidiary, PT Auro Pharm Indonesia, in Indonesia. This new entity was established on July 1, 2026, with approval received on July 9, 2026. The primary objective of PT Auro Pharm Indonesia is to undertake manufacturing operations within Indonesia. The incorporation involved an initial subscription to the share capital of IDR 20,000,000,000, representing 100% ownership by PT Aurogen Pharma Indonesia, a stepdown subsidiary of Aurobindo Pharma. This move is part of the company's strategy to expand its manufacturing footprint in the Indonesian market.
Key Highlights
- Aurobindo Pharma establishes new wholly owned subsidiary, PT Auro Pharm Indonesia.
- The subsidiary aims to conduct manufacturing operations in Indonesia.
- Initial investment of IDR 20,000,000,000 for 100% shareholding.
- The incorporation is a strategic move for market expansion.
- No governmental or regulatory approvals were required for incorporation.
Price Impact
More from AUROPHARMA